Skip to main content
Indian Dermatology Online Journal logoLink to Indian Dermatology Online Journal
. 2022 Mar 3;13(2):216–220. doi: 10.4103/idoj.idoj_393_21

Nailfold Capillaroscopic Changes as a Marker of Interstitial Lung Disease in Systemic Sclerosis: A Cross-Sectional Study in a Tertiary Care Hospital in Eastern India

Olympia Rudra 1, Subhasmita Baisya 1, Subhadeep Mallick 1,, Gobinda Chatterjee 1
PMCID: PMC8917487  PMID: 35287403

Abstract

Background:

Systemic sclerosis (SSc) is an autoimmune connective tissue disorder causing microvascular abnormality leading to Raynaud's phenomenon, skin tightening, and nailfold capillary changes. The patient may have systemic involvement, among them interstitial lung disease (ILD) and pulmonary arterial hypertension are mainly associated with disease-related mortality.

Aims:

To find out an association between nailfold capillaroscopic changes with ILD severity.

Materials and Methods:

An institution based cross-sectional study was performed among the patients of SSc above 18 years. Detailed history was taken. Clinical examinations, nailfold capillaroscopy (NFC) with a dermatoscope and high-resolution computed tomography (HRCT) scan of thorax were done. Data were analyzed in MedCalc statistical software version 20.

Results:

Out of total 43 patients, 74.4% (n = 32) were female. Mean age was 35.05 ± 7.24 years and mean duration 4.28 ± 2.81 years. Diffuse SSc was found in 88.37% (n = 38). On NFC, early, active, and late patterns were found in 30.2% (n = 13), 25.6% (n = 11), and 44.2% (n = 19) cases, respectively. On HRCT, early, active, and late ILD were present in 18.6% (n = 8), 37.2% (n = 16), and 30.2% (n = 13) cases, respectively. ILD changes were absent in 14% (n = 6) though NFC changes were present in them. Respiratory symptoms were absent in 20.93% (n = 9) patients though all had features of early NFC and among them 9.3% (n = 4) showed early ILD changes on HRCT. Significant associations were found between NFC changes and ILD severity (P = 0.0003), NFC changes and respiratory symptoms (P < 0.0001) and between ILD changes and respiratory symptoms (P < 0.0001).

Discussion:

NFC, an inexpensive procedure, can be performed in all patients of SSc to detect development of early ILD even before appearance of respiratory symptoms to prevent further progression.

Keywords: Interstitial lung disease, nailfold capillaroscopy, systemic sclerosis

Introduction

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by microvascular damage and fibrosis of the skin and internal organs. Endothelial and fibroblast dysfunction with microvascular abnormality leading to tissue hypoxia and altered immune responses play key roles in the pathogenesis. Nailfold capillaroscopy (NFC) is an established method for evaluation of microvasculature abnormalities, which characterize >95% patients with SSc, and these NFC changes may appear even before appearance of systemic manifestations.[1]

Interstitial lung disease (ILD) and pulmonary artery hypertension are the two main pulmonary manifestations of SSc and cause disease-related mortality.[2] About two-third of the patients of SSc develop scleroderma ILD (SILD).[3] High-resolution computed tomography (HRCT) is more sensitive and accurate investigation than chest radiography in detecting and characterizing diffuse lung disease in SSc. There is dearth of data regarding the impact of NFC in predicting ILD, as well as the association between extent of ILD and the NFC changes in SSc, particularly in Indian population. So, we have conducted this study.

Materials and Methods

An institute-based observational cross-sectional study was carried out in a tertiary care hospital in Eastern India and done over a period of 2 years. The study protocol was approved by Institutional ethics committee. Patients above 18 years of age fulfilling the American college of Rheumatology and European League against Rheumatism (ACR-EULAR) criteria for SSc were included in the study after informed consent. Patients with hypertension, diabetes mellitus, history of smoking, thyroid disorder, malignancy, pregnant and lactating mother, and other autoimmune connective disorders like systemic lupus erythematosus, dermatomyositis, overlap syndromes were excluded from the study.

Detailed clinical history regarding age, sex, duration, age of onset, progression, family history, systemic complaints, and treatment history were taken. Systemic and cutaneous examinations were done. Baseline investigations, serology, pulmonary function test, and HRCT of thorax were done. On HRCT, early stage of ILD consists of few ground-glass or fibro-reticular opacities in lower lobes with mild subpleural reticulation. Active stage ILD includes ground glass opacities with reticulonodular interstitial thickening in periphery of both lung fields and bulla. Late stage ILD comprises of extensive subpleural reticulation with ground-glass opacities and honey combing.[4] NFC was done with Dermatoscope (DermLite DL3N) placing immersion oil (Cedarwood oil) on the nailfold bed after proper washing of the fingers for better visualization of the capillaries. On NFC, few enlarged/giant capillaries with relatively well-preserved capillary distribution, no loss of capillaries is defined as early pattern. Active pattern is described as frequent giant capillaries and capillary hemorrhages, moderate loss of capillaries, disorganization of capillary architecture, absent or mild ramified capillaries. Late pattern includes absent giant capillaries and hemorrhages, severe loss of capillaries with extensive avascular areas, disorganization of the normal capillary array, and ramified or bushy capillaries.[1,5] It was done by a single observer, later the images were stored, processed, and interpreted by two independent observers. All 10 fingernails were examined for any abnormality after making the patient sit comfortably at ambient room temperature for 15 min. Fingers affected by recent local trauma were excluded. All relevant data were recorded in a pretested, predesigned, and semistructured schedule and later imported to Microsoft excel sheet and computed by statistical software MedCalc version 20.

Results

A total 43 patients were selected, out of which 74.4% (n = 32) were female. Mean age was 35.05 ± 7.24 years, and mean duration was 4.28 ± 2.81 years. Diffuse and limited cutaneous SSc was found in 88.37% (n = 38) and 11.63% (n = 5) cases, respectively. On NFC, early patterns (few enlarged/giant capillaries, relatively well-preserved capillary distribution) have been found in 30.2% (n = 13) [Figures 1 and 2], active patterns (frequent enlarged capillaries, capillary hemorrhages, disorganization of capillary architecture) seen in 25.6% (n = 11)

Figure 1.

Figure 1

Early pattern of NFC showing few enlarged/giant capillaries (marked by arrow)

Figure 2.

Figure 2

Few dilated capillaries with a well-preserved capillary architecture (marked by arrow) – early NFC changes

[Figures 3 and 4], and late patterns (extensive avascular areas, ramified/bushy capillaries) in 44.2% (n = 19) of patients [Figures 5 and 6], respectively. Table 1 shows details of NFC changes among study populations. On HRCT, early ILD found in 18.6% (n = 8), active and late ILD in 37.2% (n = 16), and 30.2% (n = 13) patients, respectively. ILD changes were absent in 14% (n = 6), though NFC changes were present in them. Respiratory symptoms were absent in 20.93% (n = 9) patients, though all had features of early NFC changes and among them 9.3% (n = 4) showed early ILD changes on HRCT. Table 2 shows significant associations between NFC changes with ILD severity (P = 0.0003, Chi-squared test). Significant associations were also found between NFC changes with respiratory symptoms (P < 0.0001, Chi-square test) [Table 3] and between ILD changes with respiratory symptoms (P < 0.0001, Chi-square test) [Table 4].

Figure 3.

Figure 3

Frequent enlarged capillaries with disorganization of a capillary architecture (marked by arrow) – characteristics of an active NFC pattern

Figure 4.

Figure 4

Active NFC pattern with hemorrhage (marked by arrow)

Figure 5.

Figure 5

Absent giant capillaries and hemorrhages, extensive avascular areas – late NFC pattern

Figure 6.

Figure 6

Ramified/bushy capillaries (marked by arrow) – characteristics of a late NFC pattern

Table 1.

Details of nailfold capillaroscopic changes among study populations

Nailfold capillaroscopic changes parameters Number of patients
Dilated capillaries 30 (69.76%)
Abnormal capillary morphology 43 (100%)
Presence of capillary hemorrhages 8 (18.6%)
Capillary drop outs 30 (69.76%)
Presence of avascular areas 19 (44.18%)
Bushy-ramified capillaries 6 (13.95%)

Table 2.

Associations between nailfold capillaroscopic changes and interstitial lung disease severity

Interstitial lung disease severity Nailfold capillaroscopic changes Total P

Early Active Late
No 5 1 0 6 (14%) 0.0003
Early 5 3 0 8 (18.6.%)
Active 3 5 8 16 (37.2%)
Late 0 2 11 13 (30.2%)
13 11 19 43

Table 3.

Associations between nailfold capillaroscopic changes and respiratory symptoms

Respiratory symptoms Nailfold capillaroscopic changes Total P

Early Active Late
Absent 9 0 0 9 (20.9%) <0.0001
Present 4 11 19 34 (79.1%)
13 (30.2%) 11 (25.6%) 19 (44.2%) 43

Table 4.

Associations between interstitial lung disease and respiratory symptoms

Respiratory symptoms Interstitial lung disease Total P

No ILD Early Active Late
Absent 5 4 0 0 9 (20.9%) <0.0001
Present 0 4 16 14 34 (79.1%)
5 (11.63%) 8 (18.6%) 16 (37.2%) 14 (32.56%) 43

Discussion

Abnormal NFC change has been accepted as part of ACR EULAR classification criteria of SSc, scoring two points out of the nine required for classification.[6] In 1973, Maricq et al.[7] published the first article in arthritis and rheumatism, describing the specific capillaroscopic patterns in SSc as well as the modification of the capillary blood flow during cold exposure, both in primary and secondary Raynaud's phenomenon. Nailfold capillaroscope is an expensive, nonportable device that require technical skills and training. So, we preferred dermoscopy which is portable, inexpensive simple but an effective tool to assess the capillary network of nail folds. Three defined major NFC patterns “early,” “active,” and “late” have been considered useful in determining the appearance and progression of the sclerodermic microangiopathy. In our study, the mean age was 35.05 ± 7.24 years, mean duration was 4.28 ± 2.81 years, and male: female ratio was 11:32, whereas Caetano et al.[8] found a male to female ratio of 5:43, mean age 52 ± 26 years, and age of onset was 43.5 ± 27 years. Jakhar et al.[9] found male to female ratio (0.125:1) with the mean age being 33.40 ± 9.78 years and mean disease duration was 5.8 ± 4.94 years. In our study, diffuse (dSSc) and limited (lSSc) cutaneous SSc was found in 88.37% (n = 38) and 11.63% (n = 5) cases, respectively, whereas Jakhar et al.[9] found dSSc in 73.34% (n = 33/45) cases. In our study, we found that NFC changes were present in all patients of SSc. Similar results were also observed by Piotto et al.[10] and Corrado et al.[11] Though Jakhar et al.[9] found abnormality in 97.8% (n = 44) and normal capillary morphology in 2.2% (n = 1) patients. Early, active, late NFC patterns of 30.2%, 25.6%, and 44.2%, respectively, were found in our study, whereas Cutolo et al.[1] found it 33%, 37%, and 29%, respectively, and Caetano et al.[8] demonstrated it 51.2%, 30.2%, and 18.6%, respectively. In our study, active stage of ILD was found highest in 37.2% (n = 16) followed by late and early stage. ILD changes were absent in 14% (n = 6), though NFC changes were present in all of them. Recently, Corrado et al.[11] pointed out differences in the nailfold pattern between ILD in SSc (SILD) patients and idiopathic pulmonary fibrosis (IPF), i.e., SILD patients have typical capillary loop changes even in the very early stages of disease, whereas IPF patients present only minimal capillary alterations.

In our study, significant associations were found between NFC changes and ILD severity, NFC changes and respiratory symptoms, and ILD changes and respiratory symptoms. Respiratory symptoms were absent in 20.93% (n = 9) patients, though all had features of early NFC changes, and among them 9.3% (n = 4) showed early ILD changes on HRCT. Similarly, Lovy et al.[12] and Sato et al.[13] have shown a correlation between NFC abnormalities and cutaneous and pulmonary involvement (interstitial fibrosis) in SSc patients. Caetano et al.[8] also found that capillary loss and avascular area showed a significant association with the presence of ILD. Smith et al.[14] demonstrated that late patterns of NFC were mostly associated with severe pulmonary involvement, which is concordant with our study. Castellví et al.[15] showed that the patients with capillaroscopic findings had slightly worse pulmonary function test values compared to those without, but the difference was not significant. However, no previous study has compared NFC changes with ILD severity grading like we did in this study.

Conclusion

NFC, an inexpensive simple procedure, can be performed in all patients of SSc to detect development of early ILD even before appearance of respiratory symptoms to prevent further progression. It might provide a window of opportunity for initiation and escalation of treatment in SSc individuals who are more likely to get benefit from the earlier administration of immune suppressants or vasodilators. It can be used as a basic screening tool for the assessment of disease severity in the patients of SSc. Our study opens up a scientific window for future research in larger population.

Limitation

Small sample size, limited time duration, and absence of control population are the main pitfalls of the study. Additional studies like prospective longitudinal analysis of NFC changes and HRCT along with serial measurements of pulmonary function tests can help to better define the role of NFC in diagnosis of ILD in SSc.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Acknowledgement

The authors appreciate with profound respect, the critical review and contribution in radiological evaluation (HRCT findings) of Dr. Abhishek Biswas (Department of Radiology, IPGME&R) in the preparation of this manuscript.

References

  • 1.Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases.A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) 2006;45:43–6. doi: 10.1093/rheumatology/kel310. [DOI] [PubMed] [Google Scholar]
  • 2.Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol. 2001;19:4–8. [PubMed] [Google Scholar]
  • 3.Varga J. Systemic sclerosis (scleroderma) In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2001. pp. 2546–60. [Google Scholar]
  • 4.Webb WR, Higgins CB. The idiopathic interstitial pneumonias. In: Webb WR, editor. Thoracic Imaging: Pulmonary and Cardiovascular Radiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2016. pp. 456–78. [Google Scholar]
  • 5.Chojer P, Mahajan BB. Nail fold dermoscopy in collagen vascular disorders: A cross-sectional study. Indian J Dermatol Venereol Leprol. 2019;85:439. doi: 10.4103/ijdvl.IJDVL_495_18. [DOI] [PubMed] [Google Scholar]
  • 6.Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, et al. Classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747–55. doi: 10.1136/annrheumdis-2013-204424. [DOI] [PubMed] [Google Scholar]
  • 7.Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by 'wide field' microscopy. Arthritis Rheum. 1973;16:619–28. doi: 10.1002/art.1780160506. [DOI] [PubMed] [Google Scholar]
  • 8.Caetano J, Paula FS, Amaral M, Oliveira S, Alves JD. Nailfold videocapillaroscopy changes are associated with the presence and severity of systemic sclerosis-related interstitial lung disease. J Clin Rheumatol. 2019;25:12–5. doi: 10.1097/RHU.0000000000000815. [DOI] [PubMed] [Google Scholar]
  • 9.Jakhar D, Grover C, Singal A, Das GK. Nailfold capillaroscopy and retinal findings in patients with systemic sclerosis: Is there an association? Indian Dermatol Online J. 2020;11:382–6. doi: 10.4103/idoj.IDOJ_264_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Piotto DG, Len CA, Hilario MO, Terreri MT. Nailfold capillaroscopy in children and adolescents with rheumatic diseases. Rev Bras Reumatol 012. 2:722–32. [PubMed] [Google Scholar]
  • 11.Corrado A, Carpagnano GE, Gaudio A, Foschino-Barbaro MP, Cantatore FP. Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis. Joint Bone Spine. 2010;77:570–4. doi: 10.1016/j.jbspin.2010.02.019. [DOI] [PubMed] [Google Scholar]
  • 12.Lovy M, Mac Carter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum. 1985;28:496–501. doi: 10.1002/art.1780280505. [DOI] [PubMed] [Google Scholar]
  • 13.Sato LT, Kayser C, Andrade LE. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port. 2009;34:219–27. [PubMed] [Google Scholar]
  • 14.Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, et al. ; EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy.Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19:102458. doi: 10.1016/j.autrev.2020.102458. [DOI] [PubMed] [Google Scholar]
  • 15.Castellví I, Simeón-Aznar CP, Sarmiento M, Fortuna A, Mayos M, Geli C, et al. Association between nailfold capillaroscopy findings and pulmonary function tests in patients with systemic sclerosis. J Rheumatol. 2015;42:222–7. doi: 10.3899/jrheum.140276. [DOI] [PubMed] [Google Scholar]

Articles from Indian Dermatology Online Journal are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES